Expression of VEGF- and tight junction-related proteins in the neocortical microvasculature of patients with drug-resistant temporal lobe epilepsy
The blood-brain barrier (BBB) maintains the optimal microenvironment for brain function. Tight junctions (TJs) allow endothelial cells to adhere to each other, leading to the formation of a barrier that prevents the penetration of most molecules via transcellular routes. Evidence has indicated that...
Gespeichert in:
Veröffentlicht in: | Microvascular research 2020-11, Vol.132, p.104059-104059, Article 104059 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 104059 |
---|---|
container_issue | |
container_start_page | 104059 |
container_title | Microvascular research |
container_volume | 132 |
creator | Castañeda-Cabral, José Luis Colunga-Durán, Adacrid Ureña-Guerrero, Mónica E. Beas-Zárate, Carlos Nuñez-Lumbreras, Maria de los Angeles Orozco-Suárez, Sandra Alonso-Vanegas, Mario Guevara-Guzmán, Rosalinda Deli, Maria A. Valle-Dorado, María Guadalupe Sánchez-Valle, Vicente Rocha, Luisa |
description | The blood-brain barrier (BBB) maintains the optimal microenvironment for brain function. Tight junctions (TJs) allow endothelial cells to adhere to each other, leading to the formation of a barrier that prevents the penetration of most molecules via transcellular routes. Evidence has indicated that seizure-induced vascular endothelial growth factor (VEGF) type 2 receptor (VEGFR-2) pathway activation weakens TJs, inducing vasodilatation and increasing vascular permeability and subsequent brain injury. The present study focused on investigating the expression levels of VEGF-related (VEGF-A and VEGFR-2) and TJ-related proteins (claudin-5, occludin and ZO-1) in the neocortical microvasculature of patients with drug-resistant temporal lobe epilepsy (TLE). The results obtained from hippocampal sclerosis TLE (HS-TLE) patients were compared with those obtained from patients with TLE secondary to lesions (lesion-TLE) and autopsy samples. The Western blotting and immunofluorescence results showed that VEGF-A and VEGFR-2 protein expression levels were increased in HS-TLE and lesion-TLE patients compared to autopsy group. On the other hand, claudin-5 expression was higher in HS-TLE patients and lesion-TLE patients than autopsies. The expression level of occludin and ZO-1 was decreased in HS-TLE patients. Our study described modifications to the integrity of the BBB that may contribute to the pathogenesis of TLE, in which the VEGF system may play an important role. We demonstrated that the same modifications were present in both HS-TLE and lesion-TLE patients, which suggests that seizures modify these systems and that they are not associated with the establishment of epilepsy.
•VEGF-A and VEGFR-2 are increased in microvasculature of patients with TLE.•TLE patients showed changes in expression and cellular localization of TJ proteins.•Increase of VEGF-related proteins could be related to BBB dysfunction.•Occludin and ZO-1 degradation may be involved in BBB disruption following seizures. |
doi_str_mv | 10.1016/j.mvr.2020.104059 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2434757038</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0026286220301199</els_id><sourcerecordid>2434757038</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-7c4c2151bfc5f7db52666754722a67c32af9b550c48569ee17418b3422c98cb83</originalsourceid><addsrcrecordid>eNp9kc1O3DAUhS1EBQPlAdhUXrLJ4J84jsWqQsOPhNRN263lODeMR0mc2s5QXqNPjKOBLlldXd3vHOncg9AlJWtKaHW9Ww_7sGaELXtJhDpCK0qUKBSn6hitCGFVweqKnaKzGHeEUCoUO0GnnElVC0FX6N_m7xQgRudH7Dv8e3N_V2Aztji5523Cu3m0Kd-KAL1J0OIp-ARujNiNOG0Bj-CtD8lZ0-PB2eD3Jto5s3OAxXAyycGYIn5xaYvbMD9nq-hiMmPCCYbJh6zsfQMYJtfDFF-_oi-d6SNcvM9z9Otu8_P2oXj6cf94-_2psFzwVEhbWkYFbTorOtk2glVVJUUpGTOVtJyZTjVCEFvWolIAVJa0bnjJmFW1bWp-jq4OvjnTnxli0oOLFvre5FBz1KzkpRSS8AWlBzQHjDFAp6fgBhNeNSV6qULvdK5CL1XoQxVZ8-3dfm4GaP8rPn6fgZsDADnk3kHQ0eZfWWhdAJt0690n9m9xJ5xO</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2434757038</pqid></control><display><type>article</type><title>Expression of VEGF- and tight junction-related proteins in the neocortical microvasculature of patients with drug-resistant temporal lobe epilepsy</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Castañeda-Cabral, José Luis ; Colunga-Durán, Adacrid ; Ureña-Guerrero, Mónica E. ; Beas-Zárate, Carlos ; Nuñez-Lumbreras, Maria de los Angeles ; Orozco-Suárez, Sandra ; Alonso-Vanegas, Mario ; Guevara-Guzmán, Rosalinda ; Deli, Maria A. ; Valle-Dorado, María Guadalupe ; Sánchez-Valle, Vicente ; Rocha, Luisa</creator><creatorcontrib>Castañeda-Cabral, José Luis ; Colunga-Durán, Adacrid ; Ureña-Guerrero, Mónica E. ; Beas-Zárate, Carlos ; Nuñez-Lumbreras, Maria de los Angeles ; Orozco-Suárez, Sandra ; Alonso-Vanegas, Mario ; Guevara-Guzmán, Rosalinda ; Deli, Maria A. ; Valle-Dorado, María Guadalupe ; Sánchez-Valle, Vicente ; Rocha, Luisa</creatorcontrib><description>The blood-brain barrier (BBB) maintains the optimal microenvironment for brain function. Tight junctions (TJs) allow endothelial cells to adhere to each other, leading to the formation of a barrier that prevents the penetration of most molecules via transcellular routes. Evidence has indicated that seizure-induced vascular endothelial growth factor (VEGF) type 2 receptor (VEGFR-2) pathway activation weakens TJs, inducing vasodilatation and increasing vascular permeability and subsequent brain injury. The present study focused on investigating the expression levels of VEGF-related (VEGF-A and VEGFR-2) and TJ-related proteins (claudin-5, occludin and ZO-1) in the neocortical microvasculature of patients with drug-resistant temporal lobe epilepsy (TLE). The results obtained from hippocampal sclerosis TLE (HS-TLE) patients were compared with those obtained from patients with TLE secondary to lesions (lesion-TLE) and autopsy samples. The Western blotting and immunofluorescence results showed that VEGF-A and VEGFR-2 protein expression levels were increased in HS-TLE and lesion-TLE patients compared to autopsy group. On the other hand, claudin-5 expression was higher in HS-TLE patients and lesion-TLE patients than autopsies. The expression level of occludin and ZO-1 was decreased in HS-TLE patients. Our study described modifications to the integrity of the BBB that may contribute to the pathogenesis of TLE, in which the VEGF system may play an important role. We demonstrated that the same modifications were present in both HS-TLE and lesion-TLE patients, which suggests that seizures modify these systems and that they are not associated with the establishment of epilepsy.
•VEGF-A and VEGFR-2 are increased in microvasculature of patients with TLE.•TLE patients showed changes in expression and cellular localization of TJ proteins.•Increase of VEGF-related proteins could be related to BBB dysfunction.•Occludin and ZO-1 degradation may be involved in BBB disruption following seizures.</description><identifier>ISSN: 0026-2862</identifier><identifier>EISSN: 1095-9319</identifier><identifier>DOI: 10.1016/j.mvr.2020.104059</identifier><identifier>PMID: 32798551</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adolescent ; Adult ; Blood-brain barrier ; Blood-Brain Barrier - metabolism ; Blood-Brain Barrier - pathology ; Claudin-5 ; Claudin-5 - metabolism ; Drug Resistant Epilepsy - drug therapy ; Drug Resistant Epilepsy - metabolism ; Drug Resistant Epilepsy - pathology ; Epilepsy, Temporal Lobe - drug therapy ; Epilepsy, Temporal Lobe - metabolism ; Epilepsy, Temporal Lobe - pathology ; Female ; Humans ; Male ; Microvessels ; Microvessels - metabolism ; Microvessels - pathology ; Middle Aged ; Neocortex - blood supply ; Occludin ; Occludin - metabolism ; Signal Transduction ; Temporal lobe epilepsy ; Tight junction ; Tight Junction Proteins - metabolism ; Tight Junctions - metabolism ; Tight Junctions - pathology ; Vascular Endothelial Growth Factor A - metabolism ; Vascular Endothelial Growth Factor Receptor-2 - metabolism ; VEGF ; VEGFR-2 ; Young Adult ; Zonula occludens ; Zonula Occludens-1 Protein - metabolism</subject><ispartof>Microvascular research, 2020-11, Vol.132, p.104059-104059, Article 104059</ispartof><rights>2020 Elsevier Inc.</rights><rights>Copyright © 2020 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-7c4c2151bfc5f7db52666754722a67c32af9b550c48569ee17418b3422c98cb83</citedby><cites>FETCH-LOGICAL-c353t-7c4c2151bfc5f7db52666754722a67c32af9b550c48569ee17418b3422c98cb83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.mvr.2020.104059$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32798551$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Castañeda-Cabral, José Luis</creatorcontrib><creatorcontrib>Colunga-Durán, Adacrid</creatorcontrib><creatorcontrib>Ureña-Guerrero, Mónica E.</creatorcontrib><creatorcontrib>Beas-Zárate, Carlos</creatorcontrib><creatorcontrib>Nuñez-Lumbreras, Maria de los Angeles</creatorcontrib><creatorcontrib>Orozco-Suárez, Sandra</creatorcontrib><creatorcontrib>Alonso-Vanegas, Mario</creatorcontrib><creatorcontrib>Guevara-Guzmán, Rosalinda</creatorcontrib><creatorcontrib>Deli, Maria A.</creatorcontrib><creatorcontrib>Valle-Dorado, María Guadalupe</creatorcontrib><creatorcontrib>Sánchez-Valle, Vicente</creatorcontrib><creatorcontrib>Rocha, Luisa</creatorcontrib><title>Expression of VEGF- and tight junction-related proteins in the neocortical microvasculature of patients with drug-resistant temporal lobe epilepsy</title><title>Microvascular research</title><addtitle>Microvasc Res</addtitle><description>The blood-brain barrier (BBB) maintains the optimal microenvironment for brain function. Tight junctions (TJs) allow endothelial cells to adhere to each other, leading to the formation of a barrier that prevents the penetration of most molecules via transcellular routes. Evidence has indicated that seizure-induced vascular endothelial growth factor (VEGF) type 2 receptor (VEGFR-2) pathway activation weakens TJs, inducing vasodilatation and increasing vascular permeability and subsequent brain injury. The present study focused on investigating the expression levels of VEGF-related (VEGF-A and VEGFR-2) and TJ-related proteins (claudin-5, occludin and ZO-1) in the neocortical microvasculature of patients with drug-resistant temporal lobe epilepsy (TLE). The results obtained from hippocampal sclerosis TLE (HS-TLE) patients were compared with those obtained from patients with TLE secondary to lesions (lesion-TLE) and autopsy samples. The Western blotting and immunofluorescence results showed that VEGF-A and VEGFR-2 protein expression levels were increased in HS-TLE and lesion-TLE patients compared to autopsy group. On the other hand, claudin-5 expression was higher in HS-TLE patients and lesion-TLE patients than autopsies. The expression level of occludin and ZO-1 was decreased in HS-TLE patients. Our study described modifications to the integrity of the BBB that may contribute to the pathogenesis of TLE, in which the VEGF system may play an important role. We demonstrated that the same modifications were present in both HS-TLE and lesion-TLE patients, which suggests that seizures modify these systems and that they are not associated with the establishment of epilepsy.
•VEGF-A and VEGFR-2 are increased in microvasculature of patients with TLE.•TLE patients showed changes in expression and cellular localization of TJ proteins.•Increase of VEGF-related proteins could be related to BBB dysfunction.•Occludin and ZO-1 degradation may be involved in BBB disruption following seizures.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Blood-brain barrier</subject><subject>Blood-Brain Barrier - metabolism</subject><subject>Blood-Brain Barrier - pathology</subject><subject>Claudin-5</subject><subject>Claudin-5 - metabolism</subject><subject>Drug Resistant Epilepsy - drug therapy</subject><subject>Drug Resistant Epilepsy - metabolism</subject><subject>Drug Resistant Epilepsy - pathology</subject><subject>Epilepsy, Temporal Lobe - drug therapy</subject><subject>Epilepsy, Temporal Lobe - metabolism</subject><subject>Epilepsy, Temporal Lobe - pathology</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Microvessels</subject><subject>Microvessels - metabolism</subject><subject>Microvessels - pathology</subject><subject>Middle Aged</subject><subject>Neocortex - blood supply</subject><subject>Occludin</subject><subject>Occludin - metabolism</subject><subject>Signal Transduction</subject><subject>Temporal lobe epilepsy</subject><subject>Tight junction</subject><subject>Tight Junction Proteins - metabolism</subject><subject>Tight Junctions - metabolism</subject><subject>Tight Junctions - pathology</subject><subject>Vascular Endothelial Growth Factor A - metabolism</subject><subject>Vascular Endothelial Growth Factor Receptor-2 - metabolism</subject><subject>VEGF</subject><subject>VEGFR-2</subject><subject>Young Adult</subject><subject>Zonula occludens</subject><subject>Zonula Occludens-1 Protein - metabolism</subject><issn>0026-2862</issn><issn>1095-9319</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1O3DAUhS1EBQPlAdhUXrLJ4J84jsWqQsOPhNRN263lODeMR0mc2s5QXqNPjKOBLlldXd3vHOncg9AlJWtKaHW9Ww_7sGaELXtJhDpCK0qUKBSn6hitCGFVweqKnaKzGHeEUCoUO0GnnElVC0FX6N_m7xQgRudH7Dv8e3N_V2Aztji5523Cu3m0Kd-KAL1J0OIp-ARujNiNOG0Bj-CtD8lZ0-PB2eD3Jto5s3OAxXAyycGYIn5xaYvbMD9nq-hiMmPCCYbJh6zsfQMYJtfDFF-_oi-d6SNcvM9z9Otu8_P2oXj6cf94-_2psFzwVEhbWkYFbTorOtk2glVVJUUpGTOVtJyZTjVCEFvWolIAVJa0bnjJmFW1bWp-jq4OvjnTnxli0oOLFvre5FBz1KzkpRSS8AWlBzQHjDFAp6fgBhNeNSV6qULvdK5CL1XoQxVZ8-3dfm4GaP8rPn6fgZsDADnk3kHQ0eZfWWhdAJt0690n9m9xJ5xO</recordid><startdate>202011</startdate><enddate>202011</enddate><creator>Castañeda-Cabral, José Luis</creator><creator>Colunga-Durán, Adacrid</creator><creator>Ureña-Guerrero, Mónica E.</creator><creator>Beas-Zárate, Carlos</creator><creator>Nuñez-Lumbreras, Maria de los Angeles</creator><creator>Orozco-Suárez, Sandra</creator><creator>Alonso-Vanegas, Mario</creator><creator>Guevara-Guzmán, Rosalinda</creator><creator>Deli, Maria A.</creator><creator>Valle-Dorado, María Guadalupe</creator><creator>Sánchez-Valle, Vicente</creator><creator>Rocha, Luisa</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202011</creationdate><title>Expression of VEGF- and tight junction-related proteins in the neocortical microvasculature of patients with drug-resistant temporal lobe epilepsy</title><author>Castañeda-Cabral, José Luis ; Colunga-Durán, Adacrid ; Ureña-Guerrero, Mónica E. ; Beas-Zárate, Carlos ; Nuñez-Lumbreras, Maria de los Angeles ; Orozco-Suárez, Sandra ; Alonso-Vanegas, Mario ; Guevara-Guzmán, Rosalinda ; Deli, Maria A. ; Valle-Dorado, María Guadalupe ; Sánchez-Valle, Vicente ; Rocha, Luisa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-7c4c2151bfc5f7db52666754722a67c32af9b550c48569ee17418b3422c98cb83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Blood-brain barrier</topic><topic>Blood-Brain Barrier - metabolism</topic><topic>Blood-Brain Barrier - pathology</topic><topic>Claudin-5</topic><topic>Claudin-5 - metabolism</topic><topic>Drug Resistant Epilepsy - drug therapy</topic><topic>Drug Resistant Epilepsy - metabolism</topic><topic>Drug Resistant Epilepsy - pathology</topic><topic>Epilepsy, Temporal Lobe - drug therapy</topic><topic>Epilepsy, Temporal Lobe - metabolism</topic><topic>Epilepsy, Temporal Lobe - pathology</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Microvessels</topic><topic>Microvessels - metabolism</topic><topic>Microvessels - pathology</topic><topic>Middle Aged</topic><topic>Neocortex - blood supply</topic><topic>Occludin</topic><topic>Occludin - metabolism</topic><topic>Signal Transduction</topic><topic>Temporal lobe epilepsy</topic><topic>Tight junction</topic><topic>Tight Junction Proteins - metabolism</topic><topic>Tight Junctions - metabolism</topic><topic>Tight Junctions - pathology</topic><topic>Vascular Endothelial Growth Factor A - metabolism</topic><topic>Vascular Endothelial Growth Factor Receptor-2 - metabolism</topic><topic>VEGF</topic><topic>VEGFR-2</topic><topic>Young Adult</topic><topic>Zonula occludens</topic><topic>Zonula Occludens-1 Protein - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Castañeda-Cabral, José Luis</creatorcontrib><creatorcontrib>Colunga-Durán, Adacrid</creatorcontrib><creatorcontrib>Ureña-Guerrero, Mónica E.</creatorcontrib><creatorcontrib>Beas-Zárate, Carlos</creatorcontrib><creatorcontrib>Nuñez-Lumbreras, Maria de los Angeles</creatorcontrib><creatorcontrib>Orozco-Suárez, Sandra</creatorcontrib><creatorcontrib>Alonso-Vanegas, Mario</creatorcontrib><creatorcontrib>Guevara-Guzmán, Rosalinda</creatorcontrib><creatorcontrib>Deli, Maria A.</creatorcontrib><creatorcontrib>Valle-Dorado, María Guadalupe</creatorcontrib><creatorcontrib>Sánchez-Valle, Vicente</creatorcontrib><creatorcontrib>Rocha, Luisa</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Microvascular research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Castañeda-Cabral, José Luis</au><au>Colunga-Durán, Adacrid</au><au>Ureña-Guerrero, Mónica E.</au><au>Beas-Zárate, Carlos</au><au>Nuñez-Lumbreras, Maria de los Angeles</au><au>Orozco-Suárez, Sandra</au><au>Alonso-Vanegas, Mario</au><au>Guevara-Guzmán, Rosalinda</au><au>Deli, Maria A.</au><au>Valle-Dorado, María Guadalupe</au><au>Sánchez-Valle, Vicente</au><au>Rocha, Luisa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Expression of VEGF- and tight junction-related proteins in the neocortical microvasculature of patients with drug-resistant temporal lobe epilepsy</atitle><jtitle>Microvascular research</jtitle><addtitle>Microvasc Res</addtitle><date>2020-11</date><risdate>2020</risdate><volume>132</volume><spage>104059</spage><epage>104059</epage><pages>104059-104059</pages><artnum>104059</artnum><issn>0026-2862</issn><eissn>1095-9319</eissn><abstract>The blood-brain barrier (BBB) maintains the optimal microenvironment for brain function. Tight junctions (TJs) allow endothelial cells to adhere to each other, leading to the formation of a barrier that prevents the penetration of most molecules via transcellular routes. Evidence has indicated that seizure-induced vascular endothelial growth factor (VEGF) type 2 receptor (VEGFR-2) pathway activation weakens TJs, inducing vasodilatation and increasing vascular permeability and subsequent brain injury. The present study focused on investigating the expression levels of VEGF-related (VEGF-A and VEGFR-2) and TJ-related proteins (claudin-5, occludin and ZO-1) in the neocortical microvasculature of patients with drug-resistant temporal lobe epilepsy (TLE). The results obtained from hippocampal sclerosis TLE (HS-TLE) patients were compared with those obtained from patients with TLE secondary to lesions (lesion-TLE) and autopsy samples. The Western blotting and immunofluorescence results showed that VEGF-A and VEGFR-2 protein expression levels were increased in HS-TLE and lesion-TLE patients compared to autopsy group. On the other hand, claudin-5 expression was higher in HS-TLE patients and lesion-TLE patients than autopsies. The expression level of occludin and ZO-1 was decreased in HS-TLE patients. Our study described modifications to the integrity of the BBB that may contribute to the pathogenesis of TLE, in which the VEGF system may play an important role. We demonstrated that the same modifications were present in both HS-TLE and lesion-TLE patients, which suggests that seizures modify these systems and that they are not associated with the establishment of epilepsy.
•VEGF-A and VEGFR-2 are increased in microvasculature of patients with TLE.•TLE patients showed changes in expression and cellular localization of TJ proteins.•Increase of VEGF-related proteins could be related to BBB dysfunction.•Occludin and ZO-1 degradation may be involved in BBB disruption following seizures.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>32798551</pmid><doi>10.1016/j.mvr.2020.104059</doi><tpages>1</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0026-2862 |
ispartof | Microvascular research, 2020-11, Vol.132, p.104059-104059, Article 104059 |
issn | 0026-2862 1095-9319 |
language | eng |
recordid | cdi_proquest_miscellaneous_2434757038 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Adolescent Adult Blood-brain barrier Blood-Brain Barrier - metabolism Blood-Brain Barrier - pathology Claudin-5 Claudin-5 - metabolism Drug Resistant Epilepsy - drug therapy Drug Resistant Epilepsy - metabolism Drug Resistant Epilepsy - pathology Epilepsy, Temporal Lobe - drug therapy Epilepsy, Temporal Lobe - metabolism Epilepsy, Temporal Lobe - pathology Female Humans Male Microvessels Microvessels - metabolism Microvessels - pathology Middle Aged Neocortex - blood supply Occludin Occludin - metabolism Signal Transduction Temporal lobe epilepsy Tight junction Tight Junction Proteins - metabolism Tight Junctions - metabolism Tight Junctions - pathology Vascular Endothelial Growth Factor A - metabolism Vascular Endothelial Growth Factor Receptor-2 - metabolism VEGF VEGFR-2 Young Adult Zonula occludens Zonula Occludens-1 Protein - metabolism |
title | Expression of VEGF- and tight junction-related proteins in the neocortical microvasculature of patients with drug-resistant temporal lobe epilepsy |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T12%3A29%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Expression%20of%20VEGF-%20and%20tight%20junction-related%20proteins%20in%20the%20neocortical%20microvasculature%20of%20patients%20with%20drug-resistant%20temporal%20lobe%20epilepsy&rft.jtitle=Microvascular%20research&rft.au=Casta%C3%B1eda-Cabral,%20Jos%C3%A9%20Luis&rft.date=2020-11&rft.volume=132&rft.spage=104059&rft.epage=104059&rft.pages=104059-104059&rft.artnum=104059&rft.issn=0026-2862&rft.eissn=1095-9319&rft_id=info:doi/10.1016/j.mvr.2020.104059&rft_dat=%3Cproquest_cross%3E2434757038%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2434757038&rft_id=info:pmid/32798551&rft_els_id=S0026286220301199&rfr_iscdi=true |